Skip to main content
. Author manuscript; available in PMC: 2022 Dec 28.
Published in final edited form as: Laryngoscope. 2022 Feb 10;132(11):2194–2201. doi: 10.1002/lary.30040

Fig. 3.

Fig. 3.

Increased CK14+ basal cells in iSGS-scar–(A) Gene expression data for pathologic basal cell markers CK14, CK5, TP63 in brush biopsy samples from patients with iLTS and iSGS-scar epithelium compared with normal, non-scar epithelium showing increased CK14 and CK5 expression in iSGS-scar (B) Quantitative analysis of immunohistochemical staining demonstrating increased CK14 expression in iSGS-scar compared with non-scar controls (C) Representative immunohistochemical staining for CK14. * = P < .05; CK14 = cytokeratin 14; CK5 = cytokeratin 5; TP63 = tumor protein 63.